Stock listing
NASDAQ:ELTX Elicio Therapeutics, Inc. Stock
Home listing (NASDAQ) of Elicio Therapeutics, Inc.
Follow Elicio Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ELTX
$1.45 USD -0.14 (-8.8%)
Close on Nov 20, 2026
- Day range
- $1.44 – $1.59 USDNov 20, 2026
- Volume
- 231,624 sharesNov 20, 2026
- Market cap
- $41.05M USDAt the close on Nov 20, 2026 · price × 28.31M shares outstanding
- 52-week range
- $1.25 – $16.00 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $631,965 USDMedian day 309,000 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ELTX · Home | $1.45 USD | -0.14 (-8.8%) | 231,624 | $1.47 | $1.59 | $1.44 | $1.59 | Close on Nov 20, 2026 |
| Frankfurt:9HA | €1.25 EUR | -0.17 (-12.0%) | — | €1.35 | €1.35 | €1.25 | €1.42 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ELTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.45 | -0.14 | -8.8% | $1.47 | $1.59 | $1.44 | 231,624 | |
| $1.59 | +0.16 | +11.2% | $1.44 | $1.59 | $1.38 | 549,610 | |
| $1.43 | -0.05 | -3.4% | $1.48 | $1.54 | $1.37 | 449,195 | |
| $1.48 | -0.02 | -1.3% | $1.48 | $1.55 | $1.43 | 209,497 | |
| $1.50 | -0.06 | -3.8% | $1.57 | $1.60 | $1.48 | 327,022 | |
| $1.56 | -0.07 | -4.3% | $1.59 | $1.645 | $1.55 | 232,784 | |
| $1.63 | +0.02 | +1.2% | $1.61 | $1.665 | $1.53 | 357,213 | |
| $1.61 | -0.035 | -2.1% | $1.69 | $1.77 | $1.58 | 197,081 | |
| $1.645 | +0.135 | +8.9% | $1.49 | $1.74 | $1.48 | 219,011 | |
| $1.51 | +0.11 | +7.9% | $1.40 | $1.52 | $1.25 | 756,112 | |
| $1.40 | -0.16 | -10.3% | $1.58 | $1.66 | $1.40 | 281,686 | |
| $1.56 | +0.04 | +2.6% | $1.58 | $1.64 | $1.48 | 289,096 | |
| $1.52 | -0.07 | -4.4% | $1.71 | $1.73 | $1.445 | 516,878 | |
| $1.59 | -0.09 | -5.4% | $1.75 | $1.80 | $1.535 | 330,706 | |
| $1.68 | -0.07 | -4.0% | $1.74 | $1.78 | $1.655 | 183,462 | |
| $1.75 | -0.10 | -5.4% | $1.82 | $1.89 | $1.745 | 135,951 | |
| $1.85 | +0.02 | +1.1% | $1.80 | $1.89 | $1.72 | 216,925 | |
| $1.83 | +0.13 | +7.6% | $1.67 | $1.835 | $1.655 | 342,266 | |
| $1.70 | -0.20 | -10.5% | $1.91 | $1.943 | $1.64 | 422,974 | |
| $1.90 | -0.04 | -2.1% | $1.94 | $1.98 | $1.79 | 464,082 | |
| $1.94 | +0.27 | +16.2% | $1.68 | $1.97 | $1.67 | 515,800 | |
| $1.67 | +0.10 | +6.4% | $1.57 | $1.68 | $1.52 | 269,900 | |
| $1.57 | +0.02 | +1.3% | $1.52 | $1.62 | $1.50 | 275,800 | |
| $1.55 | -0.01 | -0.6% | $1.57 | $1.595 | $1.44 | 298,100 | |
| $1.56 | -0.22 | -12.4% | $1.81 | $1.85 | $1.55 | 333,400 | |
| $1.78 | -0.01 | -0.6% | $1.78 | $1.86 | $1.763 | 169,400 | |
| $1.79 | +0.02 | +1.1% | $1.77 | $1.91 | $1.75 | 373,300 | |
| $1.77 | -0.11 | -5.9% | $1.88 | $1.88 | $1.73 | 232,000 | |
| $1.88 | -0.01 | -0.5% | $1.90 | $1.91 | $1.82 | 164,400 | |
| $1.89 | +0.08 | +4.4% | $1.83 | $1.92 | $1.785 | 306,200 | |
| $1.81 | -0.04 | -2.2% | $1.85 | $1.85 | $1.74 | 267,000 | |
| $1.85 | -0.03 | -1.6% | $1.87 | $1.92 | $1.83 | 138,900 | |
| $1.88 | -0.04 | -2.1% | $1.90 | $1.96 | $1.86 | 259,100 | |
| $1.92 | 0.00 | 0.0% | $1.93 | $1.96 | $1.81 | 200,200 | |
| $1.92 | 0.00 | 0.0% | $1.95 | $1.97 | $1.85 | 175,900 | |
| $1.92 | +0.10 | +5.5% | $1.82 | $1.96 | $1.82 | 310,200 | |
| $1.82 | -0.02 | -1.1% | $1.86 | $1.86 | $1.78 | 274,000 | |
| $1.84 | -0.01 | -0.5% | $1.85 | $1.90 | $1.77 | 452,500 | |
| $1.85 | +0.01 | +0.5% | $1.85 | $1.90 | $1.81 | 222,100 | |
| $1.84 | -0.04 | -2.1% | $1.88 | $1.90 | $1.82 | 165,400 | |
| $1.88 | +0.01 | +0.5% | $1.88 | $2.00 | $1.81 | 339,700 | |
| $1.87 | 0.00 | 0.0% | $1.87 | $1.895 | $1.84 | 195,400 | |
| $1.87 | -0.04 | -2.1% | $1.92 | $1.925 | $1.82 | 402,600 | |
| $1.91 | +0.02 | +1.1% | $1.92 | $2.02 | $1.91 | 483,600 | |
| $1.89 | +0.025 | +1.3% | $1.86 | $2.00 | $1.86 | 689,700 | |
| $1.865 | +0.095 | +5.4% | $1.79 | $1.90 | $1.785 | 340,200 | |
| $1.77 | -0.22 | -11.1% | $1.90 | $1.90 | $1.705 | 629,200 | |
| $1.99 | -0.01 | -0.5% | $2.01 | $2.02 | $1.915 | 319,000 | |
| $2.00 | -0.05 | -2.4% | $2.06 | $2.09 | $1.95 | 391,700 | |
| $2.05 | -0.06 | -2.8% | $2.14 | $2.20 | $2.02 | 445,600 | |
| $2.11 | -0.07 | -3.2% | $2.17 | $2.20 | $2.07 | 343,100 | |
| $2.18 | -0.17 | -7.2% | $2.37 | $2.375 | $2.17 | 457,400 | |
| $2.35 | -0.06 | -2.5% | $2.42 | $2.46 | $2.34 | 324,600 | |
| $2.41 | -0.09 | -3.6% | $2.50 | $2.50 | $2.36 | 487,900 | |
| $2.50 | -0.05 | -2.0% | $2.55 | $2.56 | $2.465 | 272,700 | |
| $2.55 | -0.01 | -0.4% | $2.57 | $2.61 | $2.48 | 397,600 | |
| $2.56 | -0.14 | -5.2% | $2.70 | $2.71 | $2.55 | 334,300 | |
| $2.70 | -0.14 | -4.9% | $2.84 | $2.87 | $2.70 | 412,200 | |
| $2.84 | -0.16 | -5.3% | $3.00 | $3.00 | $2.84 | 421,600 | |
| $3.00 | +0.02 | +0.7% | $3.00 | $3.05 | $2.97 | 131,200 | |
| $2.98 | -0.03 | -1.0% | $3.00 | $3.07 | $2.96 | 181,900 | |
| $3.01 | +0.03 | +1.0% | $3.00 | $3.095 | $2.98 | 223,600 | |
| $2.98 | -0.06 | -2.0% | $3.06 | $3.06 | $2.94 | 309,000 | |
| $3.04 | -0.035 | -1.1% | $3.11 | $3.11 | $3.03 | 279,200 | |
| $3.075 | -0.055 | -1.8% | $3.11 | $3.135 | $3.02 | 207,800 |
Splits
1 split · NASDAQ:ELTX · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation |
- Ticker
- NASDAQ:ELTX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 5, 2026
Elicio Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 31 slides
Latest news
Elicio Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 5, 2026
Closed $1.51 (+7.9%) on Nov 6, 2026
Elicio Therapeutics to Host Virtual KOL Event on November 11, 2026: ELI-002 7P for Metastatic and Neoadjuvant PDAC
Nov 4, 2026
Closed $1.56 (+2.6%) on Nov 4, 2026
Elicio Therapeutics Presents Late-Breaking Phase 2 AMPLIFY-7P Results at ESMO Congress 2026 and Announces Simultaneous Publication in Nature Medicine
Oct 23, 2026
Closed $1.90 (-2.1%) on Oct 23, 2026
Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026
Sep 24, 2026
Closed $1.88 (+0.5%) on Sep 24, 2026
Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference
Aug 31, 2026
Closed $2.70 (-4.9%) on Aug 31, 2026
Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
Aug 24, 2026
Closed $2.98 (-2.0%) on Aug 24, 2026
Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
Aug 13, 2026
Closed $3.09 (-1.9%) on Aug 14, 2026
Elicio Therapeutics Announces Activation of the Investigator-Initiated Phase 1 Study of Neoadjuvant ELI-002 7P for Pancreatic Ductal Adenocarcinoma
Aug 10, 2026
Closed $3.10 (-2.8%) on Aug 10, 2026
Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering
Jul 6, 2026
Closed $2.80 (-15.0%) on Jul 7, 2026
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering
Jul 2, 2026
Closed $3.22 (-37.4%) on Jul 2, 2026
Financings
Registered direct offering of shares of common stock
Aug 13, 2026
Closed: US$15M in the latest tranche · Titan Partners, a division of American Capital Partners +1
Dealers: Titan Partners, a division of American Capital Partners (lead), B. Riley Securities, Inc.
Use of proceeds: Support the planned Phase 1 development of ELI-002 7P in metastatic pancreatic cancer and advance the pipeline
Registered direct offering of common stock
Jul 2, 2026
Announced: about US$15M · Titan Partners, a division of American Capital Partners +1
Dealers: Titan Partners, a division of American Capital Partners (lead), B. Riley Securities, Inc.
Use of proceeds: Fund planned Phase 1 development of ELI-002 7P in metastatic PDAC, the pipeline and platform, working capital and general corporate purposes
At-the-market programme of shares under at-the-market program
Nov 13, 2025
Tranche closed: US$11.1M raised
Senior secured promissory note with warrants
Jun 4, 2025
Closed: US$10M raised · Warrants at US$7.75 for 60 months
Buyers: GKCC, LLC (existing investor; $10 million senior secured promissory note and warrants to purchase 103,225 shares)
Use of proceeds: With existing cash, to support operations into Q1 2026, beyond the AMPLIFY-7P Phase 2 interim analysis expected in Q3 2025
Decks
Investor Presentation (September 2026)
Investor deck · 31 slides · September 2026
Technical Presentation (June 2026)
Technical · 23 slides · Jun 24, 2026
Corporate Update (June 2026)
Corporate update · 16 slides · Jun 15, 2026
Investor Presentation (January 2026)
Investor deck · 50 slides · January 2026
Elicio Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 36 in all · newest Nov 5, 2026 · oldest 2025
- Decks
- 15 decks · latest September 2026
Where Elicio Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ELTX · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A3CY4J | LS Exchange | Germany | EUR |
| BOATS:ELTX | BOATS | United States | USD |
| Lang & Schwarz:A3CY4J | Lang & Schwarz | Germany | EUR |
| gettex:9HA | gettex | Germany | EUR |
| Dusseldorf:9HA | Dusseldorf | Germany | EUR |
| Frankfurt:9HA | Frankfurt | Germany | EUR |
| Munich:9HA | Munich | Germany | EUR |
| Tradegate:9HA | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Elicio Therapeutics, Inc.